Anaemia and oxidative stress are common features of chronic kidney disease, and both are associated with an increase in morbidity and mortality. There is growing evidence, from experimental and clinical studies, that oxidative stress may be implicated in the pathogenesis of anaemia. This study investigated the relationship between total antioxidant capacity, anaemia and serum albumin levels in 127 non-diabetic patients requiring haemodialysis. Total serum antioxidant capacity levels were determined and were found to be significantly correlated with levels of haemoglobin, haematocrit, serum albumin, serum total protein, malondialdehyde (a product of lipid peroxidation), potassium, phosphorus and alanine transaminase. There was also a significant correlation between serum albumin levels and haemoglobin and haematocrit levels. In conclusion, total antioxidant capacity was found to be inversely correlated with malondialdehyde levels and positively correlated with haemoglobin and haematocrit levels in non-diabetic patients requiring haemodialysis. Patients with high serum albumin concentrations and high total antioxidant capacity may also have high (i.e. normal) levels of haemoglobin.
Introduction
Patients with end-stage renal disease (ESRD) are characterized by increased levels of oxidative stress. 1, 2 The pathophysiology of increased oxidative stress in these patients is multifactorial, but the retention of oxidized solute due to the loss of kidney function is probably a major contributor. 1 In addition, bioincompatibility with the dialysis, microbial contamination or pyrogen content of the dialysate, 2 and erythropoietin and intravenous iron supplementation, are other potential causes of oxidative stress in ESRD. 3, 4 Oxidative stress and inflammation are common manifestations and major mediators of anaemia and many other complications of ESRD, 5 − 7 including increased susceptibility of the erythrocyte membranes to oxidation. 6 − 8 Red blood cells (RBCs) often have a short G Çelik, M Yöntem, M Bilge et al. Antioxidant capacity and anaemia circulating half-life in patients requiring haemodialysis because iron deficiency affects RBCs in several ways, increasing their exposure to the phagocytic signalling molecule, phosphatidylserine, loss of cell deformability and increasing oxidative stress. 9 It has been postulated that increased oxidative stress might cause lipid peroxidation of the cell membranes of augmented RBCs, which increases the likelihood of cell membrane damage. 10, 11 The primary defence against oxidative stress in extracellular fluids comes from a number of low molecular weight antioxidant molecules that are either water-(e.g. ascorbic acid) or lipid-soluble (e.g. vitamin E). 2 These antioxidants are either generated during normal metabolism (e.g. uric acid, bilirubin, albumin, thiols) or introduced into the body by the consumption of dietary products that are rich in antioxidants. The sum of endogenous plus exogenous antioxidants represents the total antioxidant capacity of extracellular fluids. 2, 12 The present study was designed to evaluate the relationship between anaemia, serum albumin and total antioxidant capacity in non-diabetic patients on haemodialysis.
Patients and methods

STUDY POPULATION
Non-diabetic patients attending the Dialysis Unit of Kütahya State Hospital, and a Çınar private dialysis centre in Kütahya, Turkey, were eligible for inclusion in this study, which took place in December 2009. The patients were recruited consecutively and were required to have ESRD, be > 18 years of age and have been undergoing haemodialysis for ≥ 3 months. Patients were excluded if they had any of the following conditions: an episode of acute infection in the 3 months preceding enrolment; neoplasm; severe malnutrition; severe hypoalbuminaemia (i.e. serum albumin < 2.9 g/dl); liver cirrhosis; or were clinically symptomatic for cardiac or vascular disease. At the time of the study all patients were receiving bicarbonate-buffered dialysis therapy three times per week for 4 h.
This study was performed in accordance with the Declaration of Helsinki and with the approval of the Ethics Committee of Selçuklu Medical Faculty, Selçuk University, Konya, Turkey. Written informed consent was obtained from all patients prior to their entry to the study.
STUDY ASSESSMENTS
The adequacy of dialysis was measured by Kt/V, where K is the clearance of urea by the dialyser, t is the dialysis time, and V is the volume of distribution of urea. This was calculated using the single-compartment model of Daugirdas standard urea removal ratio (URR = 100 × [1 -R], where R is the postdialysis urea [mg/dl]/predialysis urea [mg/dl] ratio) and protein catabolic rate per normalized body weight (nPCR, g/kg per day), using the formula recommended by the 2000 Kidney Disease Outcomes Quality Initiative Haemodialysis Adequacy Work Group. 13, 14 Residual urine, i.e. the urine volume of the haemodialysis patient over 24 h, and the duration that the patient had been on dialysis (in months), were also recorded.
Peripheral venous blood samples were collected from patients just prior to the start of a midweek dialysis session; 10 ml of blood was taken from the cubital vein of each patient and transferred to ethylenediaminetetra-acetic acid, heparin, and plain (non-gel) serum tubes. After coagulation, the blood specimens were centrifuged at ≤ 1300 relative centrifugal force for 10 min to separate the serum. Serum glucose, total 
STATISTICAL ANALYSES
All data were analysed using the SPSS ® statistical package, version 12.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . Data are expressed as mean ± SD values. Pearson's correlation coefficient was used to assess the correlation between total antioxidant levels and other clinical parameters. A P-value < 0.05 was considered to be statistically significant.
Results
In total, 127 non-diabetic patients requiring haemodialysis were included in this study; 65 (51%) were female and 62 (49%) were male. The demographic and clinical characteristics of the patients are presented in Table 1 .
The total mean ± SD antioxidant capacity was 4.2 ± 1.8 µmol/l (range 1.9 − 21.9) and the total mean ± SD malondialdehyde level was 9.5 ± 6.2 µmol/l (range 2.7 − 29.4). The results for all biochemical tests are presented in Table 2 .
There were significant correlations between total antioxidant capacity levels and malondialdehyde (r = −0.793, P < 0.001), potassium (r = 0.222, P = 0.027), phosphorus (r = 0.257, P = 0.010), ALT (r = 0.253, P = 0.011), haemoglobin (r = 0.265, P = 0.008), haematocrit (r = 0.268, P = 0.007), serum albumin (r = 0.265, P = 0.008) and serum total protein (r = 0.358, P < 0.001) levels. 
Antioxidant capacity and anaemia
There was a significant positive correlation between serum albumin levels and haemoglobin levels (r = 0.375, P < 0.001) and haematocrit levels (r = 0.370, P = 0.000).
Discussion
Besides enhanced oxidative stress, patients with ESRD who are undergoing haemodialysis are also at risk of inflammation. 17, 18 Oxidative stress and inflammation are highly inter-related, as different oxidant free-radicals are generated by phagocytic cells in response to inflammatory stimuli. 19, 20 Oxidative stress plays a significant role in the development of inflammation in ESRD 21 − 23 and inflammation is a well-documented factor that influences the development of oxidative stress in dialysis patients. 17 Malondialdehyde, a terminal compound of lipid peroxidation, is commonly used as a biomarker for oxidative stress. 24 The overall antioxidant capacity may provide more relevant biological information than the measurement of individual biomarkers, as it considers the cumulative effect of all antioxidants present in plasma and body fluids. An increase in antioxidant capacity of the plasma indicates absorption of antioxidants and improved in vivo antioxidant status, or the activation of an adaptation mechanism to oxidative 2 Senol et al. 25 found that patients on haemodialysis had higher serum urea levels and total antioxidant capacity compared with healthy controls. There were significant correlations between total antioxidant capacity and levels of malondialdehyde, potassium, phosphorus, ALT, haemoglobin, haematocrit, serum albumin and serum total protein in the present study. The correlations between total antioxidant capacity and haemoglobin and haematocrit were weak because changes in haemoglobin and haematocrit levels are not due solely to antioxidant status and reasons, other than the antioxidant status, may have affected these parameters. Reductions in haemoglobin levels and haematocrit levels can be caused by infection, inflammation, blood loss, lack of iron stores, functional iron deficiency, bone marrow fibrosis, secondary hyperparathyroidism or other factors. 3, 6, 9, 26 The correlations between total antioxidant capacity and potassium, phosphorus and ALT were also weak.
Anaemia is a common complication of chronic renal failure that is primarily caused by insufficient secretion of erythropoietin from diseased kidneys and improper response to erythropoietin. 26, 27 There is growing evidence, from experimental and clinical studies, that oxidative stress may be implicated in the pathogenesis of anaemia. 28 Chronic renal failure is connected with oxidative stress, which correlates with the degree of renal anaemia. 29 Furthermore, persistent inflammation may contribute to the variability in haemoglobin levels and hyporesponsiveness to erythropoietin often seen in patients with ESRD. The anaemia of inflammation is characterized by decreased iron and iron binding capacity (transferrin) levels, increased ferritin levels and the presence of iron in bone marrow macrophages, indicating impaired mobilization of iron from stores. In general, cytokines may impair iron metabolism, leading to functional iron deficiency. 30 In the study by Tutal et al. 31 increased antioxidative capacity was positively correlated with haemoglobin levels and negatively correlated with erythropoietin requirements. Agarwal et al. 32 found the serum albumin concentration to be an important predictor of baseline haemoglobin level in patients on chronic haemodialysis treatment, and an increased serum albumin concentration over time was associated with an increase in the haemoglobin level. There were significant positive correlations between the serum albumin concentration and haemoglobin levels, haematocrit levels and total antioxidant capacity in the present study. Factors that improve the serum albumin concentration may also improve haemoglobin levels in haemodialysis patients. 32 Patients with malnutrition and low plasma albumin concentrations have significantly reduced plasma antioxidant capacity, due to the diminished availability of thiol groups. 2 Serum albumin is an excellent marker of the overall health of dialysis patients. 32 In patients with high serum albumin concentrations, haemoglobin levels are also high (i.e. normal). Increases in serum albumin concentrations over time may reflect improving infection, inflammation, oxidative stress, nutrition and overall health. Furthermore, serum albumin is likely to be a surrogate for some common stimuli that suppress both erythropoietin and albumin gene synthesis. For example, malnutrition and inflammation can cause hypo albuminaemia and also suppress erythropoiesis. 32 There were some limitations to the present study. For example, data on chronic blood loss, vitamin B 12 levels and folate levels were not collected and could not, therefore, be In conclusion, the present study found that there was a relationship between total antioxidant capacity and malondialdehyde levels, haemoglobin levels and haematocrit levels, in non-diabetic patients receiving haemodialysis.
Furthermore, serum albumin, an antioxidant, was again shown to be an excellent marker of the overall health of patients requiring dialysis. In patients in whom serum albumin concentrations and total antioxidant capacity were high, haemoglobin levels were also high (i.e normal), and vice versa.
